Phase II Study of Nedaplatin+TS-1 for previously untreated patients with squamous cell lung cancer - Phase II Study of CDGP+TS-1 for previously untreated patients with squamous cell lung cancer

Toho university0 个研究点目标入组 25 人开始时间: 2012年12月17日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•History of active double cancer within 5 years. 2) Severe infection 3) History of hemoptysis with 2.5mL or more. 4) Continued bloody phlegm. 5) Received anticoagulant drug(including Aspirin over 325mg/day) within the past 10 days. 6) Perforation of the digestive tract or history of the perforation of the digestive tract within the past one year. 7) Severe comorbidity (heart failure Tendency to hemorrhages uncontrollable hypertension, uncontrollable diabetes, etc) 8) Arterial thromboembolism and Venous thromboembolism within the past one year. 9)Interstitial pneumonia or pulmonary fibrosis detectable on X ray. 10) Planning of surgery or thoracic radiotherapy during the trial. 11) Major surgical procedure 12)With a history of drug sensitivity. 13)Pregnant or lactating women or those who declined contraception. 14) Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator.

发起方